The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials

Investor logo

Warning

This publication doesn't include Faculty of Arts. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

BARKER Timothy Hugh STONE Jennifer C SEARS Kim KLUGAR Miloslav TUFANARU Catalin LEONARDI-BEE Jo AROMATARIS Edoardo MUNN Zachary

Year of publication 2023
Type Article in Periodical
Magazine / Source JBI Evidence Synthesis
MU Faculty or unit

Faculty of Medicine

Citation
web https://journals.lww.com/jbisrir/Fulltext/2023/03000/The_revised_JBI_critical_appraisal_tool_for_the.5.aspx
Doi http://dx.doi.org/10.11124/JBIES-22-00430
Keywords critical appraisal tool; methodological quality; methodology; randomized controlled trial; risk of bias
Description JBI recently began the process of updating and revising its suite of critical appraisal tools to ensure that these tools remain compatible with recent developments within risk of bias science. Following a rigorous development process led by the JBI Effectiveness Methodology Group, this paper presents the revised critical appraisal tool for the assessment of risk of bias for randomized controlled trials. This paper also presents practical guidance on how the questions of this tool are to be interpreted and applied by systematic reviewers, while providing topical examples. We also discuss the major changes made to this tool compared to the previous version and justification for why these changes facilitate best-practice methodologies in this field.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.